Literature DB >> 28624605

Transplacental exposure to environmental carcinogens: Association with childhood cancer risks and the role of modulating factors.

A Fucic1, V Guszak2, A Mantovani3.   

Abstract

Biological responses to carcinogens from environmental exposure during adulthood are modulated over years or decades. Conversely, during transplacental exposure, the effects on the human foetus change within weeks, intertwining with developmental mechanisms: even short periods of transplacental exposure may be imprinted in the organism for a lifetime. The pathways leading to childhood and juvenile cancers, such as leukaemias, neuroblastoma/brain tumours, hepatoblastoma, and Willm's tumour involve prenatally-induced genomic, epigenomic and/or non-genomic effects caused by xenobiotics. Pregnant women most often live in complex environmental settings that cause transplacental exposure of the foetus to xenobiotic mixtures. Mother-child biomonitoring should integrate the analysis of chemicals/radiation present in the living and workplace environment with relevant risk modulators related to life style. The interdisciplinary approach for transplacental cancer risk assessment in high-pressure areas should be based on an integrated model for mother-child exposure estimation via profiling the exposure level by water quality analysis, usage of emission grids, and land use maps.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Air pollution; Childhood cancer; Food; Juvenile cancer; Newborn; Pesticides; Sex-related susceptibility; Transplacental

Mesh:

Substances:

Year:  2017        PMID: 28624605     DOI: 10.1016/j.reprotox.2017.06.044

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  7 in total

Review 1.  Candidate Proficiency Test Chemicals to Address Industrial Chemical Applicability Domains for in vitro Human Cytochrome P450 Enzyme Induction.

Authors:  Miriam Naomi Jacobs; Barbara Kubickova; Eugene Boshoff
Journal:  Front Toxicol       Date:  2022-06-20

2.  Early Life Exposure to Nicotine: Postnatal Metabolic, Neurobehavioral and Respiratory Outcomes and the Development of Childhood Cancers.

Authors:  Laiba Jamshed; Genevieve A Perono; Shanza Jamshed; Alison C Holloway
Journal:  Toxicol Sci       Date:  2020-11-01       Impact factor: 4.849

3.  Infantile neuroblastoma and maternal occupational exposure to medical agents.

Authors:  Yuhki Koga; Masafumi Sanefuji; Syunichiro Toya; Utako Oba; Kentaro Nakashima; Hiroaki Ono; Shunsuke Yamamoto; Maya Suzuki; Yuri Sonoda; Masanobu Ogawa; Hiroyuki Yamamoto; Koichi Kusuhara; Shouichi Ohga
Journal:  Pediatr Res       Date:  2021-07-09       Impact factor: 3.756

4.  Validation of in vitro methods for human cytochrome P450 enzyme induction: Outcome of a multi-laboratory study.

Authors:  Camilla Bernasconi; Olavi Pelkonen; Tommy B Andersson; Judy Strickland; Iwona Wilk-Zasadna; David Asturiol; Thomas Cole; Roman Liska; Andrew Worth; Ursula Müller-Vieira; Lysiane Richert; Christophe Chesne; Sandra Coecke
Journal:  Toxicol In Vitro       Date:  2019-05-31       Impact factor: 3.500

Review 5.  Diet as a Potential Moderator for Genome Stability and Immune Response in Pediatric Leukemia.

Authors:  Shanshan Wang; Christopher A Maxwell; Neha M Akella
Journal:  Cancers (Basel)       Date:  2021-01-22       Impact factor: 6.639

6.  Prenatal exposure to nitrofurantoin and risk of childhood leukaemia: a registry-based cohort study in four Nordic countries.

Authors:  Sarah Hjorth; Anton Pottegård; Anne Broe; Caroline H Hemmingsen; Maarit K Leinonen; Marie Hargreave; Ulrika Nörby; Hedvig Nordeng
Journal:  Int J Epidemiol       Date:  2022-06-13       Impact factor: 9.685

7.  The Impact of Mother's Living Environment Exposure on Genome Damage, Immunological Status, and Sex Hormone Levels in Newborns.

Authors:  Aleksandra Fucic; Mirta Starcevic; Nada Sindicic Dessardo; Drago Batinic; Sasa Kralik; Jure Krasic; Nino Sincic; Damir Loncarevic; Vedrana Guszak
Journal:  Int J Environ Res Public Health       Date:  2020-05-13       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.